Ventures Pte. Ltd. Syngenta Net Worth

The estimated Net Worth of Ventures Pte. Ltd. Syngenta is at least $6.4 Milion dollars as of 11 February 2014. Ventures Syngenta owns over 332,027 units of Pro Farm Inc stock worth over $1,511,902 and over the last 11 years Ventures sold MBII stock worth over $4,887,437.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ventures Syngenta MBII stock SEC Form 4 insiders trading

Ventures has made over 1 trades of the Pro Farm Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Ventures sold 332,027 units of MBII stock worth $4,887,437 on 11 February 2014.

The largest trade Ventures's ever made was selling 332,027 units of Pro Farm Inc stock on 11 February 2014 worth over $4,887,437. On average, Ventures trades about 110,676 units every 0 days since 2013. As of 11 February 2014 Ventures still owns at least 1,889,877 units of Pro Farm Inc stock.

You can see the complete history of Ventures Syngenta stock trades at the bottom of the page.

What's Ventures Syngenta's mailing address?

Ventures's mailing address filed with the SEC is 1, HARBOUR FRONT AVENUE #03-03, KEPPEL BAY TOWER, , U0, 098632.

Insiders trading at Pro Farm Inc

Over the last 22 years, insiders at Pro Farm Inc have traded over $9,574,054 worth of Pro Farm Inc stock and bought 9,515,326 units worth $31,165,010 . The most active insiders traders include Ag Science Llc Ospraie Mana..., Advisory Partnersardsley Pa... a Advisory Partners Lp Ardsle.... On average, Pro Farm Inc executives and independent directors trade stock every 49 days with the average trade being worth of $690,868. The most recent stock trade was executed by Pamela G Marrone on 6 July 2022, trading 20,000 units of MBII stock currently worth $16,000.

What does Pro Farm Inc do?

Marrone Bio Innovations Inc.  is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection and plant health that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 500 issued and pending patents, MBI's currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®, Pacesetter®, Zelto® Jet-Oxide® and Jet-Ag® , with a next-generation insecticide-nematicide, a breakthrough bioherbicide and a biofumigant in the Company's product pipeline. MBI's Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include UBP™ 110, Foramin®, UBP™ Seed Treatment, Foramin® ST.

Complete history of Ventures Syngenta stock trades at Pro Farm Inc

Pro Farm Inc executives and stock owners

Pro Farm Inc executives and other stock owners filed with the SEC include:

• Pamela Marrone,
  Director
• Kevin Hammill,
  Chief Commercial Officer
• Linda Moore,
  Executive Vice President, Chief Compliance Officer, General Counsel, Secretary
• Dr. Pamela G. Marrone Ph.D.,
  Founder, Advisor & Non-Employee Director
• Robert Woods,
  Independent Chairman of the Board
• Zachary Wochok,
  Independent Director
• Yogesh Mago,
  Independent Director
• Stuart Woolf,
  Independent Director
• Keith McGovern,
  Independent Director
• Greg Falesnik,
  Managing Director (MZ North America)
• Lara Lee,
  Director
• Timothy Johnson,
  Vice President - Field Development and Technical Services
• Keith Pitts,
  Senior Vice President - Regulatory and Government Affairs, Chief Sustainability Officer
• Amit Vasavada,
  Senior Vice President - Research and Development, Chief Technology Officer
• Kevin Helash,
  Chief Executive Officer, Director
• Matti Tiainen,
  Sr. VP of International Sales
• Barner Jones,
  Director of National Sales & Account Management
• Andre Trepanier,
  Director of Marketing
• Linda V. Moore,
  Chief Compliance Officer, Chief Legal Officer & Sec.
• Clyde Montevirgen,
  VP of Bus. Devel. & Investor Relations
• Dr. Amit Vasavada Ph.D.,
  Sr. VP of Research Devel. & Chief Technical Officer
• Suping Cheung CPA, Ph.D.,
  Chief Financial Officer
• Advisory Partners Lp Ardsle...,
  
• Advisory Partnersardsley Pa...,
  
• Brian R Ahrens,
  Vice President, Sales
• Richard E Rominger,
  Director
• Michael H Benoff,
  Director
• Pamela Reilly Contag,
  Director
• Advisory Partnersardsley Pa...,
  
• Timothy T Fogarty,
  Director
• Kathleen Merrigan,
  Director
• Elin D Miller,
  Director
• James Boyd,
  President and CFO
• George H Kerckhove,
  Director
• Ag Science Llc Ospraie Mana...,
  
• Advisory Partners Lp Ardsle...,
  
• & Reed Financial Incwaddell...,
  
• Hector Absi,
  See Remarks
• Leslie F Lyman,
  Director
• Donald J Glidewell,
  CFO and Secretary
• Joseph Hudson,
  Director
• Ranjeet Bhatia,
  Director
• Lawrence A Hough,
  Director
• Phyllis Himmel,
  V.P. of Biological Research
• Alison Stewart,
  SR VP of R&D and CTO
• Ventures Pte. Ltd. Syngenta,
  10% owner
• Shaugn Stanley,
  Director
• Mill Venture Partners Lp St...,
  
• Ag Science Llc Anderson Dwi...,
  
• Advisory Partners Lpardsley...,
  
• Matti Tiainen,
  SVP, International Sales
• Ag Science Llc Ospraie Mana...,
  
• Suping (Sue) Cheung,
  Chief Financial Officer